Whitney Remily provides counseling to chemical and pharmaceutical companies in all areas of patent law. With over a decade of experience in intellectual property law, and a former research chemist for Merck & Co., Ms. Remily leverages her background in chemistry and the pharmaceutical arts to strengthen the patent positions of her clients by helping them obtain and enforce patents, rendering opinions on the validity and infringement of patents, preparing patent clearance and right to use opinions, conducting reissue and reexamination proceedings, performing due diligence reviews of patents, and developing patent estates. Committed to understanding her clients’ values, Ms. Remily provides strategic guidance which accomplishes their goals while adhering to their long-term business objectives.
Ms. Remily has significant experience with pharmaceuticals, including various aspects of the Hatch-Waxman Act, having handled patent matters relating to filings of Abbreviated New Drug Applications by generic drug manufacturers. She has also assisted clients in obtaining patent term extensions under 35 U.S.C. § 156. In addition, she has experience in other technical areas including cosmetics, agrichemicals, polymers, rubber compositions, cement compositions, cigarettes, fine chemicals and medical devices, having drafted opinions and patent applications involving such technologies.
While at Merck, Ms. Remily was involved in the synthesis of pharmaceutical compounds, as well as combinatorial chemistry approaches for lead optimization and drug discovery. During her graduate studies in organic chemistry at the Johns Hopkins University, her research related to the synthesis of novel trioxane and artmisinin analogs as anti-malarial or chemotherapeutic agents. Ms. Remily earned her B.A. with a double-major in chemistry and biology from Cornell University, where she worked as a research assistant in both the Chemistry Department and the Material Science and Engineering Department.